医药开发新动向及印度公司面临的挑战

许多医药公司在采用生物信息技术、计算机技术和组合化学方法开发新品种医药,但重要的是首先要找到主要化合物,研究的重点应更多地放在示构药物设计方面。近几年,印度公司在开发新医药品方面作了大量的工作,但也存在资金和人员不足的问题。在印度,每1分钟就有1人死于结核病,急需开发治疗结核病的新药。目前,基因技术的应用将引起新药物开发的进一步变革。

Emerging Issues in Molecule Development:Challenges for Indian Companies

Many pharmaceutical companies are looking into biological and information technology, computer-based approaches and combinatorial chemistry to develop new pharmaceuticals. It is essential for the companies first to find major compounds and greater emphasis has been placed on rational drug design. In recent years, Indian companies have been making great efforts to develop new pharmaceuticals, however, they don' t have sufficient financial resources and well-trained scientists to undertake such activities. In India, 1 person dies of T. B. every minute. Therefore, it is urgent to develop new drugs for T. B. . Recently, the application of genetic technique will lead to further changes in new drug development.